Rui Liu

9PUBLICATIONS
10CO-AUTHORS
Haematological tumoursMedical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 23, 2024
Incidence, Risk Factors, and Modified Risk Assessment Model of Venous Thromboembolism in Non-Hodgkin Lymphoma Patients.

Wen Li, Rui Liu, Ying Shen

|Nov 20, 2024
The incidence and clinical significance of monoclonal and oligoclonal protein bands in multiple myeloma patients after BCMA-CAR-T cell therapy: A retrospective study based on LEGEND-2.

Rui Liu, Gongzhizi Gao, Hongli Chen

|Feb 19, 2024
Outcomes in patients with multiple myeloma receiving salvage treatment after BCMA-specific CAR-T therapy: A retrospective analysis of LEGEND-2.

Rui Liu, Rui Yang, Xuezhu Xu

|Dec 11, 2023
Circular RNA circXPO1 Promotes Multiple Myeloma Progression by Regulating miR-495-3p/DNA Damage-Induced Transcription 4 Axis.

Fangmei Li, Jing Liu, Jiyu Miao

|Oct 05, 2023
Real-world results of venetoclax combined with hypomethylating agents in young adults with relapsed/refractory acute myeloid leukemia.

Xuezhu Xu, Rui Liu, Aili He

|Aug 09, 2023
PRMT1 methylation of WTAP promotes multiple myeloma tumorigenesis by activating oxidative phosphorylation via m6A modification of NDUFS6.

Yachun Jia, Xiao Yu, Rui Liu

Pageof 2

Frequent Collaborators

9 joint publications

Aili He

3 joint publications

Fangxia Wang

2 joint publications

Guangyao Kong

2 joint publications

Ju Bai